Patents Assigned to Spectrum Pharmaceuticals
  • Patent number: 9801874
    Abstract: Improved methods for efficiently constituting liposome encapsulated vincristine for intravenous injection (VSLI) with reduced risk of operational errors and contamination are disclosed.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: October 31, 2017
    Assignees: Spectrum Pharmaceuticals, Tekmira Pharmaceuticals Corporation
    Inventors: William T. Monte, Christopher James Barbosa, Thomas Philip Weber